Social Determinants of Health and Diabetes Mortality: Moving Beyond Clinical Interventions
Overview
This paper responds to a peer's analysis of Healthy People 2030 objective D-09, focusing on excess diabetes mortality. The author affirms the peer's emphasis on social determinants of health—including medication affordability, food insecurity, unsafe neighborhoods, and transportation limitations—as root causes that clinical interventions alone cannot address. The paper argues that achieving mortality reduction targets requires multisectoral policy interventions beyond healthcare system screening recommendations.
What this coursework covers
- Validation of peer's argument connecting family experience to public health crisis and social determinants
- Critique of limitations in clinical-only approaches to diabetes prevention and management
- Policy recommendations for upstream intervention including Medicaid expansion, insulin cost controls, and community-level programs
Preview
Response to Kishma
Kishma, your post is thoughtful and personal, and I appreciate how you connected the Healthy People 2030 objective D-09 to both your family experience and the broader public health crisis. Your emphasis on social determinants of health as root causes of excess diabetes mortality is spot-on and aligns well with current evidence.
The structural barriers you identified, medication affordability, food insecurity, unsafe neighborhoods, and transportation limitations, create a compounding effect that clinical interventions alone cannot overcome (Hill-Briggs et al., 2021). You correctly note that while USPSTF screening and prevention recommendations (Davidson et al., 2021) are valuable for early detection and risk reduction, they operate within a healthcare system that still leaves many patients unable to access insulin, continuous glucose monitors, or nutritious food.
Achieving the target reduction from 15.2 to 13.7 deaths per 1,000 person-years will require policy interventions such as expanding Medicaid coverage in non-expansion states, capping insulin copays (now partially addressed in some plans), and investing in community-level programs that improve food environments and walkability. Your analysis effectively highlights the limitations of a purely clinical approach and underscores the need for multisectoral action to address upstream determinants.
Thank you for bringing both evidence and personal insight into this important discussion.
References
Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., Kubik, M., Li, L., Ogedegbe, G., Owens, D. K., Pbert, L., Silverstein, M., Stevermer, J., Tseng, C.-W., & Wong, J. B. (2021).